Clinical experiment to find the effect of bloodletting with daily Purgation therapy for the treatment of liver disease.

A randomized comparative clinical trial study to evaluate the efficacy of ruksha purva and sneha purva siravedhana and nityavirechana in yakrutodara with special reference to non-alcoholic fatty liver disease.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/082679

Enrollment

Registered

2025-03-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either gender between the age group of 18 to 60. Patients of grade I, II, and III Non- Alcoholic fatty liver disease. Both Diagnosed and Newly diagnosed patients.

Exclusion criteria

Exclusion criteria: Patient having history of Ascites, Liver Carcinoma, Liver Cirrhosis, HIV, Anemia. Patients having history of major Systemic Diseases like IHD, Malignancies. Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
To reduce fatty liver Index score by performing Panchakarma procedures like Udvartana, Siravedhana and Nitya virechana in NAFLD.Timepoint: 13 days and follow up on 20th day	—

Secondary

Measure	Time frame
To reduce symptoms like Ajirna, Atilalastrava, Aruchi, Chardi, Adhmana, VibandhaTimepoint: On 13th day on 20th day(follow up)	—

Countries

India

Contacts

Public ContactDr Sangeeta H Toshikhane

Parul Institute of Ayurved

sangeeta.toshikhane26791@paruluniversity.ac.in9964596479

Outcome results